Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Malaria

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

How parasites evade the immune response.

Immunology today·2014

Same author

Australian parasitological research: now and in 2000.

Parasitology today (Personal ed.)·2006

Same author

Concomitant infections, parasites and immune responses.

Parasitology·2001

Same author

Elimination of lymphatic filariasis as a public health problem.

Parasitology today (Personal ed.)·2000

Same author

Killing of blood stage Plasmodium vinckei petteri by spleen macrophages through L-arginine dependent mechanism.

The Southeast Asian journal of tropical medicine and public health·1998

Same author

Control of coccidiosis: lessons from other sporozoa.

International journal for parasitology·1998

Search research articles

Related Experiment Video

Updated: Jul 28, 2026

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

Designer vaccines for parasitic diseases

¹School of Life, Health and Basic Medical Sciences, King's College London, UK. feg.cox@kcl.ac.uk

International Journal for Parasitology

|December 12, 1997

Summary

Developing new vaccines for parasitic infections requires a novel approach focusing on the immunological environment. Manipulating immune responses with cytokines can enhance vaccine efficacy, offering new strategies for diseases like leishmaniasis and schistosomiasis.

More Related Videos

Generating Genetically Modified Plasmodium berghei Sporozoites

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

Related Experiment Videos

Last Updated: Jul 28, 2026

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

Generating Genetically Modified Plasmodium berghei Sporozoites

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

Area of Science:

Immunology
Vaccinology
Parasitology

Background:

Conventional vaccine development struggles with parasitic infections due to complex immune responses.
The immunological environment, not just antigens, is crucial for effective immunity.
T helper 1 (T1) and T helper 2 (T2) cell responses, mediated by cytokines, have opposing effects on immunity.

Purpose of the Study:

To explore novel strategies for developing effective vaccines against parasitic infections.
To investigate the role of cytokines in directing immune responses for vaccine design.
To present a new approach for parasitic vaccine development by manipulating the immunological environment.

Main Methods:

Designing recombinant or nucleic acid vaccines incorporating genes for specific cytokines (e.g., IL-2, IFN-gamma, IL-12).
Utilizing novel delivery systems for vaccine candidates.
Investigating effector molecules like nitric oxide and cytokine-mediated signaling pathways.

Main Results:

Incorporating IL-2 and IFN-gamma genes into vectors induced protective immunity in experimental leishmaniasis.
Exogenous IL-12 promoted T1 responses and reduced pathology in experimental schistosomiasis.
Novel delivery systems show encouraging results for new vaccine approaches.

Conclusions:

Manipulating the immunological environment through cytokine engineering is a promising strategy for parasitic vaccine development.
Recombinant and nucleic acid vaccines encoding specific cytokines can induce protective cell-mediated immunity.
Further research into novel delivery systems and effector molecules is essential for advancing parasitic vaccine efficacy.